AstraZeneca files for U.S. approval of drug to steer clear of COVID-19

Oct 5 (Reuters) - AstraZeneca observed on Tuesday it had submitted a request with U.S. fitness regulators to grant emergency use authorisation for a new treatment to keep away from COVID-19.

The British drugmaker had observed in August that the medicine, an antibody therapy called AZD7442, had decreased the chance of people constructing any COVID-19 symptoms by using 77% in a late-stage trial. (Reporting via Sachin Ravikumar in Bengaluru; modifying via Sriraj Kalluvila)